Aurobindo Pharm Jun '11 sales at Rs 1,030.14 crore
Published on Fri, Aug 12, 2011 at 12:48 | Source : Moneycontrol.com
 0
Like this story, share it with millions of investors on M3
Aurobindo Pharm Jun '11 sales at Rs 1,030.14 crore
Aurobindo Pharma has reported a sales turnover of Rs 1,030.14 crore and a net loss of Rs 101.58 crore for the quarter ended Jun '11
|
ALSO READ
Aurobindo Pharm
BSE | NSE 01/06/12
|
Aurobindo Pharma has reported a sales turnover of Rs 1,030.14 crore and a net loss of Rs 101.58 crore for the quarter ended Jun '11.
| For the quarter ended Jun 2010 the sales turnover was Rs 867.51 crore and net profit was Rs 63.34 crore.
|
| | | Quarterly Results of Aurobindo Pharma | -------- in Rs. Cr. -------- |
| | Jun '10 | | | Mar '11 | Jun '11 | | Sales Turnover | 867.51 | | | 1,058.57 | 1,030.14 | | Other Income | 1.30 | | | 3.03 | 1.73 | | Total Income | 868.81 | | | 1,061.60 | 1,031.87 | | Total Expenses | 696.06 | | | 871.91 | 859.86 | | Operating Profit | 171.45 | | | 186.66 | 170.28 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -45.02 | | | 23.23 | -639.72 | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | 172.75 | | | 189.69 | 172.01 | | Interest | 9.09 | | | 15.49 | 8.81 | | PBDT | 118.64 | | | 197.43 | -156.66 | | Depreciation | 27.39 | | | 31.44 | 34.19 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | 91.25 | | | 165.99 | -190.85 | | Tax | 27.91 | | | 33.41 | -89.27 | | Net Profit | 63.34 | | | 132.58 | -101.58 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | 11.22 | | | 4.55 | -- | | Book Value | -- | | | -- | -- | | Equity | 28.23 | | | 29.11 | 29.11 | | Reserves | -- | | | 2,540.50 | -- | | Face Value | 5.00 | | | 1.00 | 1.00 | | Source : Religare Technova |
|
Trending News
Business News
- PM sets up mechanism to fast track project implementation
- Chic geeks give San Francisco a new tech groove
- R Systems quoting ex-dividend
- Romney gives 'F' grade to Obama's foreign policy
- Microsoft Announces Availability Of Windows 8 Release Preview
- HSBC Global buys 18.31 lakh shares of IRB Infra
- For June, accrue Nifty at around 4,800 levels HSBC Invest
- No more TDS on locally-made software, assures Finance Minister
- If you can invest Rs 50K every year, here's what you can do
- Need to raise FII invest limit in bonds RBI draft report
- BSE Sensex falls on econ worries
- IT stocks fall on global econ worries
- Sensex near day's low; IT, power, oil & gas stocks slide
- Nifty below 4850; RIL, ONGC, Infosys drag
- US markets end lower on concerns over euro zone debt crisis
- Rupee fall to aid exports, support GDP growth Taimur Baig
- Maruti May sales slip 5% on falling mini car sales, exports
- MCX SILVERM June contract falls 1.5%
- Can't arrest rupee fall if due to fundamental factors - RBI
- Indian manufacturing keeps up pace in May
|
CNBC-TV18 ALERT IGL Questioned PNGRB Tariff Order's Legality
The latest earning numbers FIRST on CNBC-TV18
Subscribe to
Moneycontrol Newsletters
|
